 | • レポートコード：QYR9N7004 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、市中肺炎（CAP）のグローバル市場について調査・分析したレポートで、種類別（胸部レントゲン写真、喀痰グラム染色および/または培養、血液培養）、用途別（病院と診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・市中肺炎（CAP）の世界市場規模 ・主要企業別市場シェア ・市中肺炎（CAP）の世界市場規模：種類別（胸部レントゲン写真、喀痰グラム染色および/または培養、血液培養） ・市中肺炎（CAP）の世界市場規模：用途別（病院と診療所、その他） ・市中肺炎（CAP）のアメリカ市場規模（種類別、用途別） ・市中肺炎（CAP）のヨーロッパ市場規模（種類別、用途別） ・市中肺炎（CAP）の中国市場規模（種類別、用途別） ・市中肺炎（CAP）の日本市場規模（種類別、用途別） ・市中肺炎（CAP）の東南アジア市場規模（種類別、用途別） ・市中肺炎（CAP）のインド市場規模（種類別、用途別） ・市中肺炎（CAP）の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・市中肺炎（CAP）の世界市場予測（2019年-2025年） ・市中肺炎（CAP）の地域別市場予測（2019年-2025年） ... |
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system.The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and Latin America.
In 2018, the global Community Acquired Pneumonia (CAP) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Community Acquired Pneumonia (CAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Community Acquired Pneumonia (CAP) development in United States, Europe and China.
The key players covered in this study
Pfizer
Astrazeneca
Bioaegis Therapeutics
Biotest
C10 Pharma
Kyorin Pharmaceutical
Melinta Therapeutics
Merck
Nabriva Therapeutics
Paratek Pharmaceuticals
Market segment by Type, the product can be split into
Chest X-ray/Radiography
Sputum Gram Stain and/or Culture
Blood Cultures
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Community Acquired Pneumonia (CAP) status, future forecast, growth opportunity, key market and key players.
To present the Community Acquired Pneumonia (CAP) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Community Acquired Pneumonia (CAP) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Community Acquired Pneumonia (CAP) Market Size Growth Rate by Type (2014-2025)
1.4.2 Chest X-ray/Radiography
1.4.3 Sputum Gram Stain and/or Culture
1.4.4 Blood Cultures
1.5 Market by Application
1.5.1 Global Community Acquired Pneumonia (CAP) Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Community Acquired Pneumonia (CAP) Market Size
2.2 Community Acquired Pneumonia (CAP) Growth Trends by Regions
2.2.1 Community Acquired Pneumonia (CAP) Market Size by Regions (2014-2025)
2.2.2 Community Acquired Pneumonia (CAP) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Community Acquired Pneumonia (CAP) Market Size by Manufacturers
3.1.1 Global Community Acquired Pneumonia (CAP) Revenue by Manufacturers (2014-2019)
3.1.2 Global Community Acquired Pneumonia (CAP) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Community Acquired Pneumonia (CAP) Market Concentration Ratio (CR5 and HHI)
3.2 Community Acquired Pneumonia (CAP) Key Players Head office and Area Served
3.3 Key Players Community Acquired Pneumonia (CAP) Product/Solution/Service
3.4 Date of Enter into Community Acquired Pneumonia (CAP) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019)
4.2 Global Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019)
5 United States
5.1 United States Community Acquired Pneumonia (CAP) Market Size (2014-2019)
5.2 Community Acquired Pneumonia (CAP) Key Players in United States
5.3 United States Community Acquired Pneumonia (CAP) Market Size by Type
5.4 United States Community Acquired Pneumonia (CAP) Market Size by Application
6 Europe
6.1 Europe Community Acquired Pneumonia (CAP) Market Size (2014-2019)
6.2 Community Acquired Pneumonia (CAP) Key Players in Europe
6.3 Europe Community Acquired Pneumonia (CAP) Market Size by Type
6.4 Europe Community Acquired Pneumonia (CAP) Market Size by Application
7 China
7.1 China Community Acquired Pneumonia (CAP) Market Size (2014-2019)
7.2 Community Acquired Pneumonia (CAP) Key Players in China
7.3 China Community Acquired Pneumonia (CAP) Market Size by Type
7.4 China Community Acquired Pneumonia (CAP) Market Size by Application
8 Japan
8.1 Japan Community Acquired Pneumonia (CAP) Market Size (2014-2019)
8.2 Community Acquired Pneumonia (CAP) Key Players in Japan
8.3 Japan Community Acquired Pneumonia (CAP) Market Size by Type
8.4 Japan Community Acquired Pneumonia (CAP) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Community Acquired Pneumonia (CAP) Market Size (2014-2019)
9.2 Community Acquired Pneumonia (CAP) Key Players in Southeast Asia
9.3 Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Type
9.4 Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Application
10 India
10.1 India Community Acquired Pneumonia (CAP) Market Size (2014-2019)
10.2 Community Acquired Pneumonia (CAP) Key Players in India
10.3 India Community Acquired Pneumonia (CAP) Market Size by Type
10.4 India Community Acquired Pneumonia (CAP) Market Size by Application
11 Central & South America
11.1 Central & South America Community Acquired Pneumonia (CAP) Market Size (2014-2019)
11.2 Community Acquired Pneumonia (CAP) Key Players in Central & South America
11.3 Central & South America Community Acquired Pneumonia (CAP) Market Size by Type
11.4 Central & South America Community Acquired Pneumonia (CAP) Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Community Acquired Pneumonia (CAP) Introduction
12.1.4 Pfizer Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Astrazeneca
12.2.1 Astrazeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Community Acquired Pneumonia (CAP) Introduction
12.2.4 Astrazeneca Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.2.5 Astrazeneca Recent Development
12.3 Bioaegis Therapeutics
12.3.1 Bioaegis Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Community Acquired Pneumonia (CAP) Introduction
12.3.4 Bioaegis Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.3.5 Bioaegis Therapeutics Recent Development
12.4 Biotest
12.4.1 Biotest Company Details
12.4.2 Company Description and Business Overview
12.4.3 Community Acquired Pneumonia (CAP) Introduction
12.4.4 Biotest Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.4.5 Biotest Recent Development
12.5 C10 Pharma
12.5.1 C10 Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Community Acquired Pneumonia (CAP) Introduction
12.5.4 C10 Pharma Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.5.5 C10 Pharma Recent Development
12.6 Kyorin Pharmaceutical
12.6.1 Kyorin Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Community Acquired Pneumonia (CAP) Introduction
12.6.4 Kyorin Pharmaceutical Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.6.5 Kyorin Pharmaceutical Recent Development
12.7 Melinta Therapeutics
12.7.1 Melinta Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Community Acquired Pneumonia (CAP) Introduction
12.7.4 Melinta Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.7.5 Melinta Therapeutics Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Community Acquired Pneumonia (CAP) Introduction
12.8.4 Merck Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Nabriva Therapeutics
12.9.1 Nabriva Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Community Acquired Pneumonia (CAP) Introduction
12.9.4 Nabriva Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.9.5 Nabriva Therapeutics Recent Development
12.10 Paratek Pharmaceuticals
12.10.1 Paratek Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Community Acquired Pneumonia (CAP) Introduction
12.10.4 Paratek Pharmaceuticals Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)
12.10.5 Paratek Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Community Acquired Pneumonia (CAP) Key Market Segments
Table Key Players Community Acquired Pneumonia (CAP) Covered
Table Global Community Acquired Pneumonia (CAP) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Community Acquired Pneumonia (CAP) Market Size Market Share by Type 2014-2025
Figure Chest X-ray/Radiography Figures
Table Key Players of Chest X-ray/Radiography
Figure Sputum Gram Stain and/or Culture Figures
Table Key Players of Sputum Gram Stain and/or Culture
Figure Blood Cultures Figures
Table Key Players of Blood Cultures
Table Global Community Acquired Pneumonia (CAP) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Community Acquired Pneumonia (CAP) Report Years Considered
Table Global Community Acquired Pneumonia (CAP) Market Size 2014-2025 (Million US$)
Figure Global Community Acquired Pneumonia (CAP) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Community Acquired Pneumonia (CAP) Market Size by Regions 2014-2025 (Million US$)
Table Global Community Acquired Pneumonia (CAP) Market Size by Regions 2014-2019 (Million US$)
Table Global Community Acquired Pneumonia (CAP) Market Share by Regions 2014-2019
Figure Global Community Acquired Pneumonia (CAP) Market Share by Regions 2014-2019
Figure Global Community Acquired Pneumonia (CAP) Market Share by Regions 2019
Table Market Top Trends
Table Global Community Acquired Pneumonia (CAP) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Community Acquired Pneumonia (CAP) Market Share by Manufacturers (2014-2019)
Figure Global Community Acquired Pneumonia (CAP) Market Share by Manufacturers in 2018
Table Global Community Acquired Pneumonia (CAP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Community Acquired Pneumonia (CAP) Product/Solution/Service
Table Date of Enter into Community Acquired Pneumonia (CAP) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table Global Community Acquired Pneumonia (CAP) Market Size Share by Type (2014-2019)
Figure Global Community Acquired Pneumonia (CAP) Market Size Market Share by Type (2014-2019)
Table Global Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table Global Community Acquired Pneumonia (CAP) Market Size Share by Application (2014-2019)
Figure Global Community Acquired Pneumonia (CAP) Market Size Market Share by Application (2014-2019)
Figure Global Community Acquired Pneumonia (CAP) Revenue Market Share by Application in 2018
Figure United States Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table United States Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table United States Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table United States Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table United States Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table United States Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table United States Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Figure Europe Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table Europe Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table Europe Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table Europe Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table Europe Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table Europe Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table Europe Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Figure China Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table China Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table China Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table China Community Acquired Pneumonia (CAP) Market Size by Type (2014-20189) (Million US$)
Table China Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table China Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table China Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Figure Japan Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table Japan Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table Japan Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table Japan Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table Japan Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table Japan Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table Japan Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Figure Southeast Asia Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Figure India Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table India Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table India Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table India Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table India Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table India Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table India Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Figure Central & South America Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019)
Table Central & South America Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019)
Table Central & South America Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Pfizer Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Astrazeneca Recent Development
Table Bioaegis Therapeutics Company Details
Table Bioaegis Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Bioaegis Therapeutics Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Bioaegis Therapeutics Recent Development
Table Biotest Company Details
Table Biotest Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Biotest Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Biotest Recent Development
Table C10 Pharma Company Details
Table C10 Pharma Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure C10 Pharma Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table C10 Pharma Recent Development
Table Kyorin Pharmaceutical Company Details
Table Kyorin Pharmaceutical Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Kyorin Pharmaceutical Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Kyorin Pharmaceutical Recent Development
Table Melinta Therapeutics Company Details
Table Melinta Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Melinta Therapeutics Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Melinta Therapeutics Recent Development
Table Merck Company Details
Table Merck Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Merck Recent Development
Table Nabriva Therapeutics Company Details
Table Nabriva Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Nabriva Therapeutics Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Nabriva Therapeutics Recent Development
Table Paratek Pharmaceuticals Company Details
Table Paratek Pharmaceuticals Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$)
Figure Paratek Pharmaceuticals Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019)
Table Paratek Pharmaceuticals Recent Development
Table Global Community Acquired Pneumonia (CAP) Market Size by Regions (Million US$) 2019-2025
Figure Global Community Acquired Pneumonia (CAP) Market Size Share by Regions (2019-2025)
Figure Global Community Acquired Pneumonia (CAP) Market Size Share by Regions in 2025
Figure United States Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Figure China Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Figure India Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD)
Table Global Community Acquired Pneumonia (CAP) Market Size by Product (2019-2025) (Million US$)
Figure Global Community Acquired Pneumonia (CAP) Market Size by Product (2019-2025)
Figure Global Community Acquired Pneumonia (CAP) Market Size by Product in 2025
Table Global Community Acquired Pneumonia (CAP) Market Size by Application (2019-2025) (Million US$)
Figure Global Community Acquired Pneumonia (CAP) Market Size by Application (2019-2025)
Figure Global Community Acquired Pneumonia (CAP) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の肺炎診断市場：市場規模・現状・予測 In 2018, the global Pneumonia Diagnostic market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Pneumonia Diagnostic status, future forecast, growth opportunity, key market and key players. The study …- 世界の院内感染診断市場：市場規模・現状・予測 In 2018, the global Hospital-acquired Infection Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Hospital-acquired Infection Diagnostics status, future forecast, growth opportunity, …
- 世界のグラム染色市場：市場規模・現状・予測 In 2018, the global Gram Staining market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Gram Staining status, future forecast, growth opportunity, key market and key players. The study obje…
- 世界の組織培養試薬市場：市場規模・現状・予測 Tissue or cell culture is the growth of cells from various organisms. Tissue culture reagents are the chemicals used for the preparation of tissue culture media. They are the major segment in cell culture supplies.In terms of demand, North America was the leading region in tissue culture reagents ma…
- 世界のグラム陽性菌感染症治療薬市場：市場規模・現状・予測 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.In 2018, the global Gram-positive Bacterial Infection Drugs market size was xx million US$ and it is expected to reach xx million US$ by …